Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects in pediatric rheumatology

A M Prieur1

  • 1Department of Pediatrics, Hôpital Necker Enfants Malades, Paris, France.

The Journal of Rheumatology. Supplement
|April 1, 1993
PubMed
Summary

Pediatric rheumatology faces ongoing challenges in defining new diseases and treatments. Advances in understanding juvenile chronic arthritis (JCA) include genetic factors and cytokine involvement, but effective therapies remain elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative tolerability of treatments for juvenile idiopathic arthritis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.

Rheumatology (Oxford, England)·2007
Same author

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Annals of the rheumatic diseases·2005
Same author

Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study.

The Journal of pediatrics·2005
Same author

Systemic juvenile idiopathic arthritis presenting in a young child with long term disability as an adolescent.

Annals of the rheumatic diseases·2004
Same author

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity.

Annals of the rheumatic diseases·2004

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Pediatric rheumatology, established in the mid-1970s, still requires advancements in clinical definitions, research, and therapeutic strategies.
  • Juvenile chronic arthritis (JCA) research has identified key roles for cytokines and genetic factors.

Purpose of the Study:

  • To address outstanding clinical, research, and therapeutic issues in pediatric rheumatology.
  • To highlight the need for clear definitions and diagnostic criteria for new rheumatologic entities.
  • To discuss current and future research directions, including antinuclear antibody research and treatment modalities.

Main Methods:

  • Review of existing research on juvenile chronic arthritis (JCA).
  • Exploration of advancements in understanding the role of cytokines and genetic factors.
  • Evaluation of therapeutic interventions, including local injections and joint replacement considerations.
  • Consideration of the psychological impact of JCA.

Main Results:

  • Cytokines and genetic factors are implicated in juvenile chronic arthritis (JCA).
  • Synthetic histone peptides offer potential for enhanced antinuclear antibody research.
  • Local triamcinolone hexacetonide injections have improved outcomes for pauciarticular JCA.
  • Joint replacement in pediatric patients necessitates individualized prosthetic design.

Conclusions:

  • Significant challenges remain in pediatric rheumatology, necessitating further research and development of diagnostic criteria.
  • While progress has been made in understanding JCA, effective systemic drug therapies are still lacking.
  • Addressing the psychological well-being of children with JCA is crucial for comprehensive care.

Related Experiment Videos